The RPH Group, with great satisfaction, informs all its customers that GMS (Shinlin Sinseng Pharmaceutical CO., LTD), a leading company in the field of Nuclear Medicine worldwide, has received an international inspection of ANVISA in the 1st fiftieth of June 2018 , which resulted in the achievement of the CERTIFICATE OF GOOD PRACTICE OF DRUG MANUFACTURING (BPF), as published in the DOU dated March 6, 2019. Among its products, GMS supplies TRODAT-1, a radiopharmaceutical distributed in Brazil exclusively by the RPH Group.
Today, RPH is the only private national radiopharmaceutical industry
producer of freeze-dried kits to have the GMP certificate. In addition, all products imported and marketed by RPH are purchased from partner companies that have this certification.
Once again, the RPH Group reaffirms its commitment to customers and is always working in favor of the regulation and registration of its products, complying with the Brazilian legislation required by the competent organizations.